Pharmaceuticals and Drug Development

  1. Pharmaceuticals and Drug Development

KalVista Announces FDA Acceptance of New Drug Application for Sebetralstat for Oral On-Demand Treatment of Hereditary Angioedema

CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)–Sep. 3, 2024– KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for sebetralstat…
Written by
  1. Pharmaceuticals and Drug Development

Discovery Park Ventures expands fund to £3m to invest in more innovative science and technology start-ups

Sandwich, Kent, UK, 4th December 2023 – Discovery Park Ventures (DPV) announces the expansion of its early-stage life science fund from £1m to £3m, in order to capitalise on exciting investment opportunities and support its existing portfolio. The fund’s investors have committed an additional £2m, which will also enable the fund to take larger stakes […]
Written by
Automated Multiorgan CT Can Predict Diabetes, Other Conditions
  1. Pharmaceuticals and Drug Development

Automated Multiorgan CT Can Predict Diabetes, Other Conditions

Medically reviewed by Drugs.com. By Elana Gotkine HealthDay Reporter FRIDAY, Aug. 16, 2024 — Automated multiorgan computed tomography (CT), including visceral fat, can predict diabetes and associated cardiometabolic conditions, according to a study published online Aug. 6 in Radiology. Yoosoo Chang, M.D., Ph.D., from Sungkyunkwan University School of Medicine in Seoul, South Korea, and colleagues […]
Written by
  1. Pharmaceuticals and Drug Development

New protein linked to early-onset dementia identified

Scientists have identified abnormal aggregates of a protein called TAF15 in the brains of individuals with early-onset dementia, known as frontotemporal dementia, where the cause was not previously known.  Most neurodegenerative diseases, including dementias, involve proteins aggregating into filaments called amyloids. In most of these diseases, researchers have identified the proteins that aggregate, allowing them […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

FDA Grants Accelerated Approval for Tecelra (afamitresgene autoleucel) Cell Therapy for the Treatment of Synovial Sarcoma

FDA Grants Accelerated Approval for Tecelra (afamitresgene autoleucel) Cell Therapy for the Treatment of Synovial Sarcoma PHILADELPHIA & OXFORD, England–(BUSINESS WIRE) August 01, 2024 — Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company working to redefine the treatment of solid tumor cancers with cell therapy, today announced U.S. Food and Drug Administration (FDA) accelerated approval of […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

Atara Biotherapeutics Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application for Tabelecleucel (Tab-cel®) for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease

Treatment for: EBV-Positive Post-Transplant Lymphoproliferative Disease Atara Biotherapeutics Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application for Tabelecleucel (Tab-cel®) for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease THOUSAND OAKS, Calif.–(BUSINESS WIRE) July 17, 2024 — Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic […]
Written by
Body Composition Patterns Linked to Risk of Neurodegenerative Diseases
  1. Pharmaceuticals and Drug Development

Body Composition Patterns Linked to Risk of Neurodegenerative Diseases

Medically reviewed by Drugs.com. By Elana Gotkine HealthDay Reporter WEDNESDAY, July 24, 2024 — Specific body composition patterns are associated with neurodegenerative diseases and brain aging, according to a study published online July 24 in Neurology. Shishi Xu, M.D., Ph.D., from the West China Hospital of Sichuan University in Chengdu, and colleagues conducted a retrospective […]
Written by
  1. Pharmaceuticals and Drug Development

Vilnius University Scientists’ Research on Bacterial Defense from Viruses Was Published in Science

CRISPR-Cas systems provide interference against invading foreign nucleic acids by different mechanisms. In bacteria, several different types of antiviral CRISPR-Cas systems are found, which differ in Cas proteins and their functions. Currently, the best-known Cas9 and Cas12 proteins are widely used as genome editing tools. A team of researchers led by Gintautas Tamulaitis is studying […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

FDA Approves Arcutis’ Zoryve (roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to 6 Years of Age

WESTLAKE VILLAGE, Calif., July 09, 2024 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Zoryve (roflumilast) cream, 0.15%, for the treatment of mild to moderate atopic […]
Written by

Good Reads

Worlwide

Hornet-eating frog shows remarkable venom resistance

Hornet-eating frog shows remarkable venom resistance

A frog with an unexpectedly strong resistance to venom has been identified, and it routinely eats hornets despite the insects’ dangerous stingers. Researchers believe this species may become a useful model organism for exploring how animals develop tolerance to venom. For many people, even glimpsing a hornet’s stinger is enough to cause alarm. Yet certain […]
Written by

Trending

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.